دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Unleashing the Power of Artificial Intelligence and Fusion Magnetic Resonance Imaging–Targeted Biopsy: Transforming Prostate Cancer Diagnosis
Louis Lenfant a,b,*, Thomas Seisen a , Morgan Roupreˆt a , Ugo Pinar a , Pierre C. Mozer a,b
doi : 10.1016/j.euo.2023.06.013
Volume 6, Issue 6, December 2023, Pages 541-542
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool
Giorgio Gandaglia a,b,*, Francesco Barletta a,b , Daniele Robesti a,b , Simone Scuderi a,b , Pawel Rajwa c,d , Juan Gomez Rivas e , Laura Ibanez e , Timo F.W. Soeterik f , Lorenzo Bianchi g , Luca Afferi h , Claudia Kesch i,j , Christopher Darr i,j , Hongqian Guo k , Junlong Zhuang k , Fabio Zattoni l , Wolfgang Fendler m , Giancarlo Marra n , Armando Stabile a , Daniele Amparore o , Nicolai A. Huebner c , Alexander Giesen p , Steven Joniau p , Riccardo Schiavina g , Eugenio Brunocilla g , Agostino Mattei h , Fabrizio Dal Moro l , Jesus Moreno Sierra e , Francesco Porpiglia n , Maria Picchio b,q , Roderick van den Bergh f , Shahrokh F. Shariat c , Francesco Montorsi a,b , Alberto Briganti
doi : 10.1016/j.euo.2023.05.003
Volume 6, Issue 6, December 2023, Pages 543-552
Development and External Validation of a Novel Nomogram to Predict the Probability of Pelvic Lymph-node Metastases in Prostate Cancer Patients Using Magnetic Resonance Imaging and Molecular Imaging with Prostate-specific Membrane Antigen Positron Emission Tomography
Andre´ N. Vis a,b,y, Dennie Meijer a,b,c,y,*, Matthew J. Roberts d,e,f , Amila R. Siriwardana d , Andrew Morton d,g , John W. Yaxley d,g,h , Hemamali Samaratunga g,i , Louise Emmett j,k , Peter M. van de Ven l , Martijn W. Heymans l , Jakko A. Nieuwenhuijzen a,b , Henk G. van der Poel a,b , Maarten L. Donswijk m , Thierry N. Boellaard n , Ivo G. Schoots n,o , Phillip Stricker p,q , Anne-Maree Haynes q , Daniela E. Oprea-Lager c , Geoffrey D. Coughlin g,h , Pim J. van Leeuwen
doi : 10.1016/j.euo.2023.03.010
Volume 6, Issue 6, December 2023, Pages 553-563
Navigating Nomograms To Identify Prostate Cancer Patients for Lymph Node Dissection
Pierre I. Karakiewicz a , Reha-Baris Incesu a,b,*, Lukas Scheipner a,c , Markus Graefen
doi : 10.1016/j.euo.2023.07.001
Volume 6, Issue 6, December 2023, Pages 564-565
Digital Rectal Examination Is Not a Useful Screening Test for Prostate Cancer
Agne Krilaviciute a,y, Nikolaus Becker a,y, Jale Lakes b , Jan Philipp Radtke b , Markus Kuczyk c , Inga Peters c,à , Nina N. Harke c , Ju¨rgen Debus d,e , Stefan A. Koerber d , Kathleen Herkommer f , Ju¨rgen E. Gschwend f , Valentin H. Meissner f , Axel Benner g , Petra Seibold a , Glen Kristiansen h , Boris Hadaschik i,j , Christian Arsov b,§ , Lars Schimmo¨ller k , Frederik Lars Giesel l , Gerald Antoch k , Marcus Makowski m , Frank Wacker n , Heinz-Peter Schlemmer o , Rudolf Kaaks p,|| , Peter Albers
doi : 10.1016/j.euo.2023.09.008
Volume 6, Issue 6, December 2023, Pages 566-573
Head-to-Head Comparison of 18F-PSMA-1007 Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging with Whole-mount Histopathology as Reference in Localisation and Staging of Primary Prostate Cancer
Leonie Exterkate a,y,*, Rick Hermsen b,y, Heidi V.N. Ku¨sters-Vandevelde c , Jeroen F. Prette d , Diederik J.H. Baas a,e , Diederik M. Somford a,e , Jean-Paul A. van Basten a
doi : 10.1016/j.euo.2023.04.006
Volume 6, Issue 6, December 2023, Pages 574-581
Predictors of Recurrence After Metastasis-directed Therapy in Oligorecurrent Prostate Cancer Following Radical Prostatectomy
Uros Milenkovic a,b,y,*, Joke Kuijk a,y, Eduard Roussel b , Gaetan Devos b , Thomas Van den Broeck b , Henri Van Eecke b , Arthur Vanderstichele b , Thibault Duvillier b , Lieven Verhamme a , Wim Van Haute a , Lieven Goeman a , Charlien Berghen c , Steven Joniau a,b,y, Gert De Meerleer
doi : 10.1016/j.euo.2023.02.010
Volume 6, Issue 6, December 2023, Pages 582-589
Oncological Outcomes for Patients with European Association of Urology Very High-risk Non–muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy
Roberto Contieri a,b , Patrick J. Hensley c , Wei Shen Tan a , Valentina Grajales a , Kelly Bree a , Graciela M. Nogueras-Gonzalez d , Byron H. Lee a , Neema Navai a , Colin P. Dinney a , Ashish M. Kamat
doi : 10.1016/j.euo.2023.07.012
Volume 6, Issue 6, December 2023, Pages 590-596
Radiation-based Therapy for Muscle-invasive Bladder Cancer: Contemporary Outcomes Across Tertiary Centers
Ronald Kool a,b , Gautier Marcq a,c,d , Rodney H. Breau e , Peter C. Black f , Bobby Shayegan g , Michael Kim h , Ionut Busca e , Hamidreza Abdi e , Mark T. Dawidek f , Michael Uy g , Gagan Fervaha i , Fabio L. Cury a,j , Nimira S. Alimohamed k , Jonathan I. Izawa l , Claudio Jeldres m , Ricardo Rendon n , D. Robert Siemens i , Girish S. Kulkarni h , Wassim Kassouf
doi : 10.1016/j.euo.2023.03.004
Volume 6, Issue 6, December 2023, Pages 597-603
Perioperative Complications and Oncologic Outcomes of Nephrectomy Following Immune Checkpoint Inhibitor Therapy: A Multicenter Collaborative Study
Wesley Yip a,y, Alireza Ghoreifi a,y, Thomas Gerald b , Randall Lee c , Jeffrey Howard b , Aeen Asghar a,c , Abhinav Khanna d , Jie Cai a , Manju Aron a , Inderbir Gill a , R. Houston Thompson d , Robert Uzzo c , Vitaly Margulis b , Nirmish Singla e , Hooman Djaladat
doi : 10.1016/j.euo.2023.03.003
Volume 6, Issue 6, December 2023, Pages 604-610
Comparative Effectiveness Analysis of Treatment Strategies for Surgically Resectable Neuroendocrine Carcinoma of the Urinary Tract
Omar Alhalabi a,y,*, Nathaniel Wilson b,y, Lianchun Xiao c , Yiyun Lin d,e , Jaanki Khandelwal b , Mohammad Jad Moussa a , Pavlos Msaouel a,f,g , Neema Navai h , Jianjun Gao a , Ashish M. Kamat h , Patrick Pilie a , Amishi Y. Shah a , Sangeeta Goswami a , Surena Matin h , Craig Kovitz a , Vijaykumar Holla i , Charles Guo j , Bogdan Czerniak j , Christopher Logothetis a , Paul G. Corn a , Colin P.N. Dinney h , Matthew T. Campbell a , Donna E. Hansel k , Nizar M. Tannir a , Arlene O. Siefker-Radtke
doi : 10.1016/j.euo.2023.09.004
Volume 6, Issue 6, December 2023, Pages 611-620
Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted Biopsy in Clinically Significant Prostate Cancer Detection Rate? A Systematic Review and Meta-analysis
Alessandro Uleri a,b,*, Michael Baboudjian c , Alessandro Tedde a , Andrea Gallioli a , Thibaut Long-Depaquit c , Joan Palou a , Giuseppe Basile a,d , Josep Maria Gaya a , Francesco Sanguedolce a , Giovanni Lughezzani b,e , Pawel Rajwa f,g , Benjamin Pradere h , Morgan Roupret i , Alberto Briganti d , Guillaume Ploussard h , Alberto Breda
doi : 10.1016/j.euo.2023.08.001
Volume 6, Issue 6, December 2023, Pages 621-628
Prostate Imaging after Focal Ablation (PI-FAB): A Proposal for a Scoring System for Multiparametric MRI of the Prostate After Focal Therapy
Francesco Giganti a,b,*, Louise Dickinson a , Cle´ment Orczyk b,c , Aiman Haider d , Alex Freeman d , Mark Emberton b,c , Clare Allen a,y, Caroline M. Moore
doi : 10.1016/j.euo.2023.04.007
Volume 6, Issue 6, December 2023, Pages 629-634
Re: Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography–based Lymph Node Atlas for Salvage Radiotherapy in Patients with Recurrent Prostate Cancer: A Validation of the New NRG Oncology 2020 Guideline
Giorgio Gandaglia a,b,* Alberto Briganti a,b Arturo Chiti b,c Cesare Cozzarini d Francesco Montorsi a,
doi : 10.1016/j.euo.2023.04.001
Volume 6, Issue 6, December 2023, Pages 635-636
Reply to Daniel D. Shapiro, Jose A. Karam, Viraj A. Master, et al.’s Letter to the Editor re: Wesley Yip, Alireza Ghoreifi, Thomas Gerald, et al. Perioperative Complications and Oncologic Outcomes of Nephrectomy Following Immune Checkpoint Inhibitor Therapy: A Multicenter Collaborative Study. Eur Urol Oncol. Eur Urol. Onc. 2023;604–610
Wesley Yip * Alireza Ghoreifi Hooman Djaladat
doi : 10.1016/j.euo.2023.05.010
Volume 6, Issue 6, December 2023, Page 637
Re: Wesley Yip, Alireza Ghoreifi, Thomas Gerald, et al. Perioperative Complications and Oncologic Outcomes of Nephrectomy Following Immune Checkpoint Inhibitor Therapy: A Multicenter Collaborative Study. Eur Urol Oncol. Eur Urol. Onc. 2023;604–610
Daniel D. Shapiro a,* Jose A. Karam b Viraj A. Master c Wade J. Sexton d Surena F. Matin b Philippe E. Spiess d Edwin Jason Abel
doi : 10.1016/j.euo.2023.05.007
Volume 6, Issue 6, December 2023, Pages 638-639
Re: David Pasquier, Thomas Lacornerie, Stéphane Supiot, et al. The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study. Eur Urol Oncol. Eur Urol Oncol. 2023;6:399–405
Nikolaos Grivas a,b,* Christos Zampaftis b Dimitris Ermidis b Ioannis Leotsakos b Ioannis Katafigiotis b Markos Karavitakis
doi : 10.1016/j.euo.2023.03.001
Volume 6, Issue 6, December 2023, Page 640
Corrigendum to “Proposal for a Novel Histological Scoring System as a Potential Grading Approach for Muscle-invasive Urothelial Bladder Cancer Correlating with Disease Aggressiveness and Patient Outcomes� [European Urology Oncology (2023)]
Markus Eckstein a,b,c , Christian Matek a,b,c , Paul Wagner a,b,c , Ramona Erber a,b,c , Maike Bu¨ttner-Herold a,b,c,d , Peter J. Wild e , Helge Taubert f , Sven Wach f , Danijel Sikic f , Bernd Wullich f , Carol I. Geppert a,b,c , Eva M. Compe´rat g , Antonio Lopez-Beltran h , Rodolfo Montironi i , Liang Cheng j,k , Theodorus van der Kwast l , Maurizio Colecchia m , Bas W.G. van Rhijn n,o , Mahul B. Amin p,q , George J. Netto r , Jan Lehmann s,t , Michael Sto¨ckle u , Kerstin Junker u , Arndt Hartmann a,b,c , Simone Bertz
doi : 10.1016/j.euo.2023.09.023
Volume 6, Issue 6, December 2023, Page 641
